Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s Guidelines
The article presents recommendations on infectious endocarditis (IE) prevention and treatment, according to the latest evidence on risk-benefit ratio for each intervention. IE in anamnesis, prosthetic valves or other artificial implants, surgery-created ducts, complicated congenital heart disease wi...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2005-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/988 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850041424485023744 |
|---|---|
| author | A. A. Demin |
| author_facet | A. A. Demin |
| author_sort | A. A. Demin |
| collection | DOAJ |
| description | The article presents recommendations on infectious endocarditis (IE) prevention and treatment, according to the latest evidence on risk-benefit ratio for each intervention. IE in anamnesis, prosthetic valves or other artificial implants, surgery-created ducts, complicated congenital heart disease with cyanosis, are regarded as high-risk situations. IE prevention, focused on Streptococcus viridans and NACEK microorganisms before dental, respiratory or esophageal interventions, and on Enterococci and Streptococcus bovis before gastro-intestinal and urogenital interventions, is performed with amoxicillin and clindamycin. Ethiotropic antimicrobial therapy includes penicillins, cephalosporins, aminoglycosides, and vancomycine. Indications for surgery are: heart failure due to acute aortic or mitral regurgitation; resistant fever and bacteriemia for 8 days and longer, despite adequate antimicrobial therapy; abscesses, fistulas, ruptures of one or more valves; heart blocks; myocarditis – the signs of process dissemination, and antibiotic-resistant flora involvement (fungi, Brucella, Coxiella). |
| format | Article |
| id | doaj-art-1edeebf13e90401f915e422029df5d61 |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2005-08-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-1edeebf13e90401f915e422029df5d612025-08-20T02:55:48Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252005-08-01446065702Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s GuidelinesA. A. Demin0Novosibirsk State Medical Academy, Ministry of Health of the Russian Federation NovosibirskThe article presents recommendations on infectious endocarditis (IE) prevention and treatment, according to the latest evidence on risk-benefit ratio for each intervention. IE in anamnesis, prosthetic valves or other artificial implants, surgery-created ducts, complicated congenital heart disease with cyanosis, are regarded as high-risk situations. IE prevention, focused on Streptococcus viridans and NACEK microorganisms before dental, respiratory or esophageal interventions, and on Enterococci and Streptococcus bovis before gastro-intestinal and urogenital interventions, is performed with amoxicillin and clindamycin. Ethiotropic antimicrobial therapy includes penicillins, cephalosporins, aminoglycosides, and vancomycine. Indications for surgery are: heart failure due to acute aortic or mitral regurgitation; resistant fever and bacteriemia for 8 days and longer, despite adequate antimicrobial therapy; abscesses, fistulas, ruptures of one or more valves; heart blocks; myocarditis – the signs of process dissemination, and antibiotic-resistant flora involvement (fungi, Brucella, Coxiella).https://cardiovascular.elpub.ru/jour/article/view/988infectious endocarditispreventiontreatmentevidence-based medicine |
| spellingShingle | A. A. Demin Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s Guidelines Кардиоваскулярная терапия и профилактика infectious endocarditis prevention treatment evidence-based medicine |
| title | Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s Guidelines |
| title_full | Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s Guidelines |
| title_fullStr | Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s Guidelines |
| title_full_unstemmed | Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s Guidelines |
| title_short | Prevention and treatment of infectious endocarditis – evidence-based medicine approach in the European Society of Cardiology’s Guidelines |
| title_sort | prevention and treatment of infectious endocarditis evidence based medicine approach in the european society of cardiology s guidelines |
| topic | infectious endocarditis prevention treatment evidence-based medicine |
| url | https://cardiovascular.elpub.ru/jour/article/view/988 |
| work_keys_str_mv | AT aademin preventionandtreatmentofinfectiousendocarditisevidencebasedmedicineapproachintheeuropeansocietyofcardiologysguidelines |